← Leaderboards
Erik Rytting
University Of Texas Med Br Galveston
$1,086,122
Attributed
$1,947,709
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $416.9K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,947,709 · 2
By mechanism
R01$1,517,246 · 1
R21$430,463 · 1
Top collaborators
- Gary D Hankins3 shared
- Bing Tian2 shared
- Jia Zhou2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Maged Costantine$5,049,405
- Ramkumar Menon$9,581,117
- Chia Wei Hsu$139,236
- Radek K. Bukowski$1,081,861
- Bing Tian$143,488
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroDoseDrug KineticsPharmaceutical PreparationsInvestigationResponseOralSamplingFetal MedicineEstradiolFetalAllelesAffectBirthFutureDrug ExposureAgreementData AnalysesEnrollmentCyp2c9 GeneCervix UteriCervical RipeningBaseClinical Practice
Grant awards (6)
Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases$192,543
R21 · FY2025 · AI
Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases$237,920
R21 · FY2024 · AI
Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy$368,022
R01 · FY2018 · HD · contact PI
Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy$368,022
R01 · FY2017 · HD
Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy$364,342
R01 · FY2016 · HD
Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy$416,860
R01 · FY2015 · HD